{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:49:49Z","timestamp":1791506989579,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Hunan Province","award":["2026JJ80998"],"award-info":[{"award-number":["2026JJ80998"]}]},{"name":"the Natural Science Foundation of Hunan Province","award":["2024JJ5567"],"award-info":[{"award-number":["2024JJ5567"]}]},{"name":"the Natural Science Foundation of Hunan Province","award":["2023JJ40939"],"award-info":[{"award-number":["2023JJ40939"]}]},{"name":"the Natural Science Foundation of China","award":["82474131"],"award-info":[{"award-number":["82474131"]}]},{"name":"the Natural Science Foundation of China","award":["81502542"],"award-info":[{"award-number":["81502542"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03423-2","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:39:41Z","timestamp":1791459581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A20 promotes OPN ubiquitination and degradation to inhibit cell growth and invasion in human hepatocellular carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Xiangqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qigang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"issue":"4","key":"3423_CR1","first-page":"e70090","volume":"76","author":"H Sung","year":"2026","unstructured":"Sung H, Filho AM, Laversanne M, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries. CA Cancer J Clin. 2026;76(4):e70090.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3423_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","volume":"7","author":"Hepatocellular carcinoma","year":"2021","unstructured":"Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):7.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3423_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5582\/bst.2022.01061","volume":"16","author":"N Wen","year":"2022","unstructured":"Wen N, Cai Y, Li F, Ye H, Tang W, Song P, et al. The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update. Biosci Trends. 2022;16(1):20\u201330.","journal-title":"Biosci Trends"},{"issue":"10","key":"3423_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3423_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ctrv.2018.11.002","volume":"72","author":"JL Raoul","year":"2019","unstructured":"Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treat Rev. 2019;72:28\u201336.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"3423_CR6","doi-asserted-by":"publisher","first-page":"729","DOI":"10.6004\/jnccn.2020.7529","volume":"18","author":"E Cheng","year":"2020","unstructured":"Cheng E, Hung P, Wang SY. Geographic Variations of Potentially Curative Treatments for Hepatocellular Carcinoma in the United States: A SEER-Medicare Study. J Natl Compr Canc Netw. 2020;18(6):729\u201336.","journal-title":"J Natl Compr Canc Netw"},{"issue":"15","key":"3423_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"issue":"10127","key":"3423_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301\u201314.","journal-title":"Lancet"},{"issue":"4","key":"3423_CR9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/hep.31582","volume":"73","author":"Z Song","year":"2021","unstructured":"Song Z, Chen W, Athavale D, Ge X, Desert R, Das S, et al. Osteopontin Takes Center Stage in Chronic Liver Disease. Hepatology. 2021;73(4):1594\u2013608.","journal-title":"Hepatology"},{"issue":"1","key":"3423_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/0008-5472.CAN-14-0615","volume":"75","author":"X Fan","year":"2015","unstructured":"Fan X, He C, Jing W, Zhou X, Chen R, Cao L, et al. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis. Cancer Res. 2015;75(1):86\u201397.","journal-title":"Cancer Res"},{"key":"3423_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018;59:17\u201324.","journal-title":"Clin Biochem"},{"key":"3423_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-4598-6-18","volume":"6","author":"B Desai","year":"2007","unstructured":"Desai B, Rogers MJ, Chellaiah MA. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer. 2007;6:18.","journal-title":"Mol Cancer"},{"key":"3423_CR13","doi-asserted-by":"publisher","unstructured":"Iida T, Wagatsuma K, Hirayama D, Nakase H. Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases? Int J Mol Sci. 201 8 ;19(1) :7. https:\/\/doi.org\/10.3390\/ijms19010007","DOI":"10.3390\/ijms19010007"},{"issue":"1","key":"3423_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11684-014-0312-8","volume":"8","author":"L Qin","year":"2014","unstructured":"Qin L. Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies. Front Med. 2014;8(1):24\u201332.","journal-title":"Front Med"},{"issue":"9","key":"3423_CR15","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.7150\/ijbs.16445","volume":"12","author":"Y Wen","year":"2016","unstructured":"Wen Y, Jeong S, Xia Q, Kong X. Role of Osteopontin in Liver Diseases. Int J Biol Sci. 2016;12(9):1121\u20138.","journal-title":"Int J Biol Sci"},{"issue":"14","key":"3423_CR16","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1111\/febs.13644","volume":"283","author":"S Kupka","year":"2016","unstructured":"Kupka S, Reichert M, Draber P, Walczak H. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death. FEBS J. 2016;283(14):2626\u201339.","journal-title":"FEBS J"},{"issue":"7000","key":"3423_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O\u2019Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 2004;430(7000):694\u20139.","journal-title":"Nature"},{"issue":"2","key":"3423_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1158\/2159-8290.CD-11-0172","volume":"2","author":"AC Bellail","year":"2012","unstructured":"Bellail AC, Olson JJ, Yang X, Chen ZJ, Hao C. A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma. Cancer Discov. 2012;2(2):140\u201355.","journal-title":"Cancer Discov"},{"issue":"2","key":"3423_CR19","doi-asserted-by":"publisher","first-page":"e1000319","DOI":"10.1371\/journal.pbio.1000319","volume":"8","author":"AB Hjelmeland","year":"2010","unstructured":"Hjelmeland AB, Wu Q, Wickman S, Eyler C, Heddleston J, Shi Q, et al. Targeting A20 decreases glioma stem cell survival and tumor growth. PLoS Biol. 2010;8(2):e1000319.","journal-title":"PLoS Biol"},{"issue":"7","key":"3423_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1517\/14728220903045018","volume":"13","author":"Q Guo","year":"2009","unstructured":"Guo Q, Dong H, Liu X, Wang C, Liu N, Zhang J, et al. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target. Expert Opin Ther Targets. 2009;13(7):733\u201341.","journal-title":"Expert Opin Ther Targets"},{"issue":"18","key":"3423_CR21","doi-asserted-by":"publisher","first-page":"12424","DOI":"10.1016\/S0021-9258(18)42292-2","volume":"267","author":"AW Opipari Jr","year":"1992","unstructured":"Opipari AW Jr., Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem. 1992;267(18):12424\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"3423_CR22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4049\/jimmunol.156.3.1166","volume":"156","author":"M Jaattela","year":"1996","unstructured":"Jaattela M, Mouritzen H, Elling F, Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol. 1996;156(3):1166\u201373.","journal-title":"J Immunol"},{"issue":"32","key":"3423_CR23","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1038\/sj.onc.1210269","volume":"26","author":"JA Vendrell","year":"2007","unstructured":"Vendrell JA, Ghayad S, Ben-Larbi S, Dumontet C, Mechti N, Cohen PA. A20\/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. Oncogene. 2007;26(32):4656\u201367.","journal-title":"Oncogene"},{"issue":"1\u20133","key":"3423_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jsbmb.2005.01.019","volume":"94","author":"O Golovko","year":"2005","unstructured":"Golovko O, Nazarova N, Tuohimaa P. A20 gene expression is regulated by TNF, Vitamin D and androgen in prostate cancer cells. J Steroid Biochem Mol Biol. 2005;94(1\u20133):197\u2013202.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"3423_CR25","doi-asserted-by":"publisher","first-page":"e62223","DOI":"10.1371\/journal.pone.0062223","volume":"8","author":"L Shao","year":"2013","unstructured":"Shao L, Oshima S, Duong B, Advincula R, Barrera J, Malynn BA, et al. A20 restricts wnt signaling in intestinal epithelial cells and suppresses colon carcinogenesis. PLoS ONE. 2013;8(5):e62223.","journal-title":"PLoS ONE"},{"issue":"2","key":"3423_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41419-020-2278-6","volume":"11","author":"Y Feng","year":"2020","unstructured":"Feng Y, Zhang Y, Cai Y, Liu R, Lu M, Li T, et al. A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma. Cell Death Dis. 2020;11(2):89.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3423_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.molcel.2011.04.028","volume":"43","author":"W Jiang","year":"2011","unstructured":"Jiang W, Wang S, Xiao M, Lin Y, Zhou L, Lei Q, et al. Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol Cell. 2011;43(1):33\u201344.","journal-title":"Mol Cell"},{"issue":"16","key":"3423_CR28","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1200\/JCO.2007.15.6521","volume":"26","author":"XD Zhu","year":"2008","unstructured":"Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. 2008;26(16):2707\u201316.","journal-title":"J Clin Oncol"},{"issue":"31","key":"3423_CR29","doi-asserted-by":"publisher","first-page":"28593","DOI":"10.1074\/jbc.M303445200","volume":"278","author":"R Das","year":"2003","unstructured":"Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase\/Akt signaling pathways in breast cancer cells. J Biol Chem. 2003;278(31):28593\u2013606.","journal-title":"J Biol Chem"},{"issue":"37","key":"3423_CR30","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.3748\/wjg.v21.i37.10573","volume":"21","author":"N Tsuchiya","year":"2015","unstructured":"Tsuchiya N, Sawada Y, Endo I, Saito K, Uemura Y, Nakatsura T. Biomarkers for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol. 2015;21(37):10573\u201383.","journal-title":"World J Gastroenterol"},{"issue":"43","key":"3423_CR31","doi-asserted-by":"publisher","first-page":"e12954","DOI":"10.1097\/MD.0000000000012954","volume":"97","author":"T Sun","year":"2018","unstructured":"Sun T, Li P, Sun D, Bu Q, Li G. Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis. Med (Baltim). 2018;97(43):e12954.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3423_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfm246","volume":"103","author":"SK Ramaiah","year":"2008","unstructured":"Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008;103(1):4\u201313.","journal-title":"Toxicol Sci"},{"issue":"4","key":"3423_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41419-022-04806-9","volume":"13","author":"Q Wu","year":"2022","unstructured":"Wu Q, Li L, Miao C, Hasnat M, Sun L, Jiang Z, et al. Osteopontin promotes hepatocellular carcinoma progression through inducing JAK2\/STAT3\/NOX1-mediated ROS production. Cell Death Dis. 2022;13(4):341.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3423_CR34","first-page":"135","volume":"11","author":"N Shijubo","year":"2000","unstructured":"Shijubo N, Uede T, Kon S, Nagata M, Abe S. Vascular endothelial growth factor and osteopontin in tumor biology. Crit Rev Oncog. 2000;11(2):135\u201346.","journal-title":"Crit Rev Oncog"},{"issue":"5","key":"3423_CR35","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1349-7006.2010.01524.x","volume":"101","author":"H Huang","year":"2010","unstructured":"Huang H, Zhang XF, Zhou HJ, Xue YH, Dong QZ, Ye QH, et al. Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection. Cancer Sci. 2010;101(5):1314\u20139.","journal-title":"Cancer Sci"},{"issue":"4","key":"3423_CR36","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1245\/s10434-013-3445-0","volume":"21","author":"W Zhu","year":"2014","unstructured":"Zhu W, Guo L, Zhang B, Lou L, Lin Z, Zhu X, et al. Combination of osteopontin with peritumoral infiltrating macrophages is associated with poor prognosis of early-stage hepatocellular carcinoma after curative resection. Ann Surg Oncol. 2014;21(4):1304\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"3423_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s11684-018-0632-1","volume":"13","author":"W Rong","year":"2019","unstructured":"Rong W, Zhang Y, Yang L, Feng L, Wei B, Wu F, et al. Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma. Front Med. 2019;13(2):250\u20138.","journal-title":"Front Med"},{"issue":"1","key":"3423_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ijc.28953","volume":"136","author":"AN da Costa","year":"2015","unstructured":"da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, et al. Osteopontin and latent-TGF beta binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma. Int J Cancer. 2015;136(1):172\u201381.","journal-title":"Int J Cancer"},{"issue":"10","key":"3423_CR39","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41575-022-00620-y","volume":"19","author":"P Johnson","year":"2022","unstructured":"Johnson P, Zhou Q, Dao DY, Lo YMD. Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(10):670\u201381.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3423_CR40","doi-asserted-by":"publisher","unstructured":"Zhu M, Zheng J, Wu F, Kang B, Liang J, Heskia F et al. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis. J Med Virol. 2020; 92: 3596\u20133603. https:\/\/doi.org\/10.1002\/jmv.25704","DOI":"10.1002\/jmv.25704"},{"issue":"3","key":"3423_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12032-014-0367-z","volume":"32","author":"T Ge","year":"2015","unstructured":"Ge T, Shen Q, Wang N, Zhang Y, Ge Z, Chu W, et al. Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Med Oncol. 2015;32(3):59.","journal-title":"Med Oncol"},{"issue":"3","key":"3423_CR42","doi-asserted-by":"publisher","first-page":"e0151069","DOI":"10.1371\/journal.pone.0151069","volume":"11","author":"ES Jang","year":"2016","unstructured":"Jang ES, Jeong SH, Kim JW, Choi YS, Leissner P, Brechot C. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma. PLoS ONE. 2016;11(3):e0151069.","journal-title":"PLoS ONE"},{"issue":"3","key":"3423_CR43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1245\/s10434-012-2749-9","volume":"20","author":"C Zhou","year":"2013","unstructured":"Zhou C, Zhou HJ, Zhang XF, Lou LL, Ye QH, Zheng Y, et al. Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma. Ann Surg Oncol. 2013;20(3):929\u201337.","journal-title":"Ann Surg Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03423-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03423-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03423-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:03:03Z","timestamp":1791504183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03423-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3423"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03423-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Xiangya Hospital of Central South University. Written informed consent was obtained from all participants in accordance with the Declaration of Helsinki and relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"320"}}